The University of Arkansas at Little Rock is a public research university in Little Rock, Arkansas. Established as Little Rock Junior College by the Little Rock School District in 1927, the institution became a private four-year university under the name Little Rock University in 1957.

During the past decade, University of Arkansas conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 8 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Arkansas" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials, followed by "National Center for Research Resources (NCRR)" with 2 trials sponsored, "National Eye Institute (NEI)" with 2 trials sponsored, "Target PharmaSolutions, Inc." with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Arkansas" #1 collaborator was "University of Alabama at Birmingham" with 2 trials as a collaborator, "ALN Implants Chirurgicaux" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Apollo Endosurgery, Inc." with 1 trials as a collaborator and "Argon Medical Devices" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "University of Arkansas" are "Multiple Myeloma" (3 trials), "Food Hypersensitivity" (2 trials), "Herpes Simplex" (2 trials), "Multiple Sclerosis" (2 trials) and "Optic Neuritis" (2 trials). Many other conditions were trialed in "University of Arkansas" in a lesser frequency.

Most popular intervention types in "University of Arkansas" are "Drug" (28 trials), "Device" (4 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Dexamethasone" (2 trials), "Methylprednisolone" (2 trials), "Pomalidomide" (2 trials) and "Prednisone" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Arkansas" are 39 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "University of Arkansas". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in University of Arkansas, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of Arkansas, 9 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 4 trials that are defined as “Not Applicable".